Since dysregulation of SRF and NIK has been implicated in many inflammatory diseases including hypertension, restenosis, atherosclerosis, aneurysms and cancer, the role of SM22 in the pathogenesis of these diseases warrants further investigation. Here, MAP3K14 is linked to cancer.